InsidersTradesSigma
Total declarations
Companies
▲ Purchases (3 ops.)
▼ Sales (0 ops.)
Insider track record
OtherDisclosed buys
3
Disclosed sells
0
T+90 hit rate
0%
T+90 mean return
-2.8%
Across 3 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Explore the full record of transactions filed by EGLINTON MANNER CARRIE. Director active across 5 companies, notably REPLIGEN CORP. Aggregated, 18 filings have been logged. Breakdown: 3 buys · 0 sell. Total volume traded: €432k. History available since 13 May 2021. The latest transaction was filed on 15 May 2025 (Attribution). Regulator: SEC (Form 4). The full history is openly available.
Declarations18 total
973 shares0Common StockSEC:0000950170-25-074747:0
462,414 shares0Common StockSEC:0001062993-25-004316:0
28,670 shares@ US$3.48894.2% of flowCommon StockSEC:0001062993-25-004056:0
Ideal exit: 25 Nov 2025 (T+270)
78,625 shares@ US$3.146310.3% of flowCommon StockSEC:0001062993-25-003843:0
Ideal exit: 24 Nov 2025 (T+270)
401,618 shares@ US$4.6574.9% of flowCommon StockSEC:0001062993-24-012025:0
701 shares0Common StockSEC:0000950170-24-062601:0
260,688 shares0Common StockSEC:0001062993-24-005509:0
47,211 shares@ US$5.4810.6% of flowCommon StockSEC:0001062993-23-013045:0
686 shares0Common StockSEC:0000899243-23-013670:0
258,065 shares0Common StockSEC:0001062993-23-005964:0
625 shares@ US$175.02100.0% of flowCommon StockSEC:0000899243-22-038565:0
Ideal exit: 11 Dec 2022 (T+270)
814,830 shares@ US$4.9091.80% mcap100.0% of flowCommon StockSEC:0001062993-22-014386:0
1,024 shares0Common StockSEC:0000899243-22-020272:0
16,162 shares@ US$130.090.010% mcap92.5% of flowCommon StockSEC:0001022079-22-000056:0
3,915 shares0Common StockSEC:0001022079-22-000029:0
1,368 shares@ US$130.090.0008% mcap7.5% of flowCommon StockSEC:0001022079-22-000011:0
457 shares0Common StockSEC:0000899243-21-019713
457 shares0Common StockSEC:0000899243-21-019713:0
18 of 18 declarations
About EGLINTON MANNER CARRIE
Carrie Eglinton Manner is a director at Repligen CORP, and she also holds positions at Quest Diagnostics INC and ORASURE TECHNOLOGIES INC.
